US STOCK
RDY Stock Analysis
US stocks · market data · technical indicators
Dr. Reddy's Laboratories Limited American Depositary Shares
RDYUS stocksQuote delayed 15 min
9/11 上午08:36 updated
$11.71
-0.17-1.43%
Open
$11.86
High
$11.86
Low
$11.67
Volume
293.02萬
RDY price history
-5.49%Open
12.39
Latest
11.71
High
12.42
Low
11.71
Average
12.13
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score45
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$11.71
Target Price$11.125
Change %-1.43%
Institutional
Net Selling
Foreign Ownership
Reducing
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
27.88x
ROE
8.84%
P/B Ratio
14.39x
Dividend Yield
0.70%
Market Insight
The score sits in neutral territory (45/100). Waiting for a clearer signal may be warranted.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
RDY - Dr. Reddy's Laboratories Limited
EPS
0.42USD
Forward EPS
0.65USD
P/E
27.88x
Forward P/E
17.89x
P/B
14.39x
ROE
8.84%
ROA
4.01%
Operating margin
4.25%
Profit margin
10.00%
Revenue growth
-5.60%
Earnings growth
-68.70%
Dividend yield
0.70%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $80.70B | $75.16B | $87.27B | $88.05B | $85.45B |
| Gross profit | $37.54B | $43.03B | $46.81B | $48.14B | $48.63B |
| Operating income | $3.03B | $829.00M | $14.33B | $17.87B | $16.84B |
| Net income | $4.43B | $2.21B | $12.10B | $14.37B | $14.18B |
| Basic EPS | 5.32 | 2.65 | 14.53 | 17.26 | 17.04 |
| Diluted EPS | 5.32 | 2.65 | 14.52 | 17.25 | 17.02 |
Estimates vs actuals
Next earnings
2026-10-22
EPS estimate
—
Revenue estimate
$84.51B
Last surprise
+11.56%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-22 | — | Not reported | — |
| 2025-05-09 | 17.13 | 19.11 | +11.56% |
| 2025-01-23 | 16.15 | 16.94 | +4.86% |
| 2024-11-05 | 17.69 | 15.83 | -10.54% |
| 2024-07-27 | 17.12 | 16.70 | -2.50% |
| 2024-05-07 | 13.55 | 15.54 | +14.70% |
| 2024-01-30 | 13.26 | 16.64 | +25.43% |
| 2023-10-27 | 11.60 | 17.81 | +53.56% |
| 2023-07-26 | 10.51 | 16.85 | +60.42% |
| 2023-05-10 | 10.90 | 12.00 | +10.16% |
| 2023-01-25 | 9.55 | 14.84 | +55.33% |
| 2022-10-28 | 9.39 | 13.50 | +43.74% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| BlackRock Inc. | 2024-06-30 | $137.3M | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $106.5M | 0.15% |
| VANGUARD GROUP INC | 2025-12-31 | $70.6M | 0.00% |
| STATE STREET CORP | 2026-06-30 | $59.8M | 0.00% |
| CITADEL ADVISORS LLC | 2026-06-30 | $1.1M | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$13.41
Target range
$11.39 – $15.44
Implied upside
14.53%
Strong buy
0
Buy
2
Hold
2
Sell
1
Strong sell
0
Dividends
Annual yield
0.55%
Frequency
Annual
Recent payouts
- 2026-07-24$0.0643
- 2025-07-25$0.0715
- 2024-07-30$0.4042
Advertisement